e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neutrophil degranulation and oxidative profile in patients with alpha-1 antitrypsin deficiency under hypoxic conditions
M. Magallón Serrano (Valencia, Spain), D. Pellicer (Valencia, Spain), S. Castillo (Valencia, Spain), L. Bañuls (Valencia, Spain), M. Navarro-García (Valencia, Spain), A. Escribano (Valencia, Spain), F. Dasi Fernandez (Valencia, Spain)
Source:
International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session:
New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Session type:
Thematic Poster
Number:
4062
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Magallón Serrano (Valencia, Spain), D. Pellicer (Valencia, Spain), S. Castillo (Valencia, Spain), L. Bañuls (Valencia, Spain), M. Navarro-García (Valencia, Spain), A. Escribano (Valencia, Spain), F. Dasi Fernandez (Valencia, Spain). Neutrophil degranulation and oxidative profile in patients with alpha-1 antitrypsin deficiency under hypoxic conditions. 4062
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Hypoxia induces proinflammatory cytokines production in alpha-1 antitrypsin deficiency patients
Source: Virtual Congress 2021 – Pathogenic progress in airway diseases
Year: 2021
LSC Abstract – Increased oxidative stress leads to telomere shortening in children with alpha-1 antitrypsin deficiency
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Neutrophil elastase gene expression and relation with lung function in Alpha-1 Antitrypsin deficiency patients.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Neutrophil inflammation of large airways in alpha 1-antityrpsin deficiency
Source: Eur Respir J 2002; 20: Suppl. 38, 282s
Year: 2002
Oxidative stress in serum of patients with alpha-1 antitrypsin deficiency
Source: Annual Congress 2013 –New perspectives of lung function assessment in children
Year: 2013
Oxidative stress in TGF-β1-mediated fibrosis in Z alpha-1 antitrypsin cells
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Characterisation of alpha-1 antitrypsin protein expression and secretion in natural killer cells from healthy volunteers and alpha-1 antitrypsin deficiency patients
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents
Source: Eur Respir J 2008; 31: 252-260
Year: 2008
Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Regulation of neutrophil function by hypoxia
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004
Alpha-1 antitrypsin protects protein phospholipid transfer protein from cleavage to counter lung inflammatory responses
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Inhibition of neutrophil elastase contributes to attenuationof lipopolysaccharide-induced acute lung injuryduring neutropenia recovery in mice
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Evidence that cathepsin G counteracts the profibrotic effects of neutrophil elastase following lung injury
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept